- Home
- ZIM vs TARS Comparison
ZIM vs TARS Comparison
Compare ZIM & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIM
- TARS
- Stock Information
- Founded
- ZIM 1945
- TARS 2016
- Country
- ZIM Israel
- TARS United States
- Employees
- ZIM N/A
- TARS N/A
- Industry
- ZIM Marine Transportation
- TARS Medicinal Chemicals and Botanical Products
- Sector
- ZIM Consumer Discretionary
- TARS Health Care
- Exchange
- ZIM Nasdaq
- TARS Nasdaq
- Market Cap
- ZIM 1.6B
- TARS 1.7B
- IPO Year
- ZIM 2021
- TARS 2020
- Fundamental
- Price
- ZIM $14.76
- TARS $51.69
- Analyst Decision
- ZIM Sell
- TARS Strong Buy
- Analyst Count
- ZIM 4
- TARS 7
- Target Price
- ZIM $13.23
- TARS $67.14
- AVG Volume (30 Days)
- ZIM 5.2M
- TARS 679.4K
- Earning Date
- ZIM 08-20-2025
- TARS 11-12-2025
- Dividend Yield
- ZIM 48.37%
- TARS N/A
- EPS Growth
- ZIM N/A
- TARS N/A
- EPS
- ZIM 16.63
- TARS N/A
- Revenue
- ZIM $8,575,100,000.00
- TARS $295,521,000.00
- Revenue This Year
- ZIM N/A
- TARS $33,170.29
- Revenue Next Year
- ZIM N/A
- TARS N/A
- P/E Ratio
- ZIM $0.89
- TARS N/A
- Revenue Growth
- ZIM 43.57
- TARS 254.45
- 52 Week Low
- ZIM $11.04
- TARS $30.23
- 52 Week High
- ZIM $30.15
- TARS $59.76
- Technical
- Relative Strength Index (RSI)
- ZIM 53.75
- TARS 46.25
- Support Level
- ZIM $13.13
- TARS $48.20
- Resistance Level
- ZIM $15.21
- TARS $59.76
- Average True Range (ATR)
- ZIM 0.43
- TARS 2.04
- MACD
- ZIM 0.20
- TARS -1.29
- Stochastic Oscillator
- ZIM 78.87
- TARS 30.19
About ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.